•
China-based Green Valley (Shanghai) Pharmaceuticals Co., Ltd. and Vazyme Biotech Co., Ltd (SHA: 688105) have entered into a strategic partnership to collaborate on the screening, diagnosis, and early intervention of Alzheimer’s disease (AD). Collaboration GoalsThe partnership will leverage the strengths of both companies to: Strategic SynergiesBy combining their expertise, Green…